Notably, lower and higher expression of PSMA2 and PSMA6 corresponded with poor prognosis in AML [42] and were linked to higher rates of complete remission (CR) achieved in the M5 subtype [43]. The gene discussed is PSMA6; the disease is acute myeloid leukemia.